APGE
Price
$39.19
Change
-$8.27 (-17.43%)
Updated
Jul 7, 03:57 PM (EDT)
Capitalization
2.77B
56 days until earnings call
IGMS
Price
$1.36
Change
-$0.00 (-0.00%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
81.86M
35 days until earnings call
Interact to see
Advertisement

APGE vs IGMS

Header iconAPGE vs IGMS Comparison
Open Charts APGE vs IGMSBanner chart's image
Apogee Therapeutics
Price$39.19
Change-$8.27 (-17.43%)
Volume$900
Capitalization2.77B
IGM Biosciences
Price$1.36
Change-$0.00 (-0.00%)
Volume$11.46K
Capitalization81.86M
APGE vs IGMS Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. IGMS commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and IGMS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (APGE: $47.46 vs. IGMS: $1.36)
Brand notoriety: APGE and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 69% vs. IGMS: 93%
Market capitalization -- APGE: $2.77B vs. IGMS: $81.86M
APGE [@Biotechnology] is valued at $2.77B. IGMS’s [@Biotechnology] market capitalization is $81.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while IGMS’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 4 bearish.
  • IGMS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, APGE is a better buy in the short-term than IGMS.

Price Growth

APGE (@Biotechnology) experienced а +8.33% price change this week, while IGMS (@Biotechnology) price change was +11.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.35%. For the same industry, the average monthly price growth was +13.82%, and the average quarterly price growth was -0.82%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

IGMS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.77B) has a higher market cap than IGMS($81.9M). APGE YTD gains are higher at: 4.768 vs. IGMS (-77.741). IGMS has higher annual earnings (EBITDA): -178.4M vs. APGE (-241.42M). APGE has more cash in the bank: 513M vs. IGMS (152M). APGE has less debt than IGMS: APGE (11.8M) vs IGMS (44M). IGMS has higher revenues than APGE: IGMS (2.68M) vs APGE (0).
APGEIGMSAPGE / IGMS
Capitalization2.77B81.9M3,380%
EBITDA-241.42M-178.4M135%
Gain YTD4.768-77.741-6%
P/E RatioN/AN/A-
Revenue02.68M-
Total Cash513M152M338%
Total Debt11.8M44M27%
TECHNICAL ANALYSIS
Technical Analysis
APGEIGMS
RSI
ODDS (%)
Bearish Trend 5 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
79%
MACD
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 20 days ago
78%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
83%
Aroon
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FINSX48.040.50
+1.05%
Fidelity Advisor New Insights I
SUSSX15.530.13
+0.84%
State Street Instl US Equity Svc
PAGYX21.530.12
+0.56%
Putnam Dynamic Asset Allocation Gr Y
SOIAX8.210.03
+0.37%
Spirit of America Real Estate Inc&Gr Ins
TIQIX30.940.06
+0.19%
Touchstone Non-US Equity Y

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+7.08%
SYRE - APGE
54%
Loosely correlated
+1.68%
CRNX - APGE
53%
Loosely correlated
+1.22%
ATXS - APGE
52%
Loosely correlated
+1.40%
ERAS - APGE
51%
Loosely correlated
-0.69%
KRYS - APGE
51%
Loosely correlated
+1.22%
More

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+3.03%
MRSN - IGMS
56%
Loosely correlated
+3.50%
CRNX - IGMS
49%
Loosely correlated
+1.22%
DYN - IGMS
47%
Loosely correlated
-2.01%
APGE - IGMS
43%
Loosely correlated
+7.08%
APLS - IGMS
43%
Loosely correlated
+2.47%
More